FDA panel mulls over Covid booster issues despite ‘insufficient data’
The following is an excerpt from MedPage. All the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about on Wednesday in terms of a plan for Covid boosters is that they need more data. FDA staff charged VRBPAC […]
FDA panel mulls over Covid booster issues despite ‘insufficient data’ Read More »
